Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?

Nowiński A, Ufnal M.

Nutrition. 2018 Feb;46:7-12. doi: 10.1016/j.nut.2017.08.001. Epub 2017 Aug 7. Review.

PMID:
29290360
2.

Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats.

Huć T, Nowinski A, Drapala A, Konopelski P, Ufnal M.

Pharmacol Res. 2017 Dec 26. pii: S1043-6618(17)31091-5. doi: 10.1016/j.phrs.2017.12.025. [Epub ahead of print]

PMID:
29287686
3.

Gut bacteria-derived molecules as mediators and markers in cardiovascular diseases. The role of the gut-blood barrier.

Nowiński A, Ufnal M.

Kardiol Pol. 2018;76(2):320-327. doi: 10.5603/KP.a2017.0204. Epub 2017 Nov 13. No abstract available.

4.

Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.

Engel M, Endesfelder D, Schloter-Hai B, Kublik S, Granitsiotis MS, Boschetto P, Stendardo M, Barta I, Dome B, Deleuze JF, Boland A, Müller-Quernheim J, Prasse A, Welte T, Hohlfeld J, Subramanian D, Parr D, Gut IG, Greulich T, Koczulla AR, Nowinski A, Gorecka D, Singh D, Gupta S, Brightling CE, Hoffmann H, Frankenberger M, Hofer TP, Burggraf D, Heiss-Neumann M, Ziegler-Heitbrock L, Schloter M, Zu Castell W.

PLoS One. 2017 Jul 13;12(7):e0180859. doi: 10.1371/journal.pone.0180859. eCollection 2017.

5.

Centrally administered TNF increases arterial blood pressure independently of nitric oxide synthase.

Żera T, Nowiński A, Kwiatkowski P.

Neuropeptides. 2016 Aug;58:67-72. doi: 10.1016/j.npep.2016.05.002. Epub 2016 May 25.

PMID:
27241175
6.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

7.

Achieving low-fouling surfaces with oppositely charged polysaccharides via LBL assembly.

Wei Y, Hung HC, Sun F, Bai T, Zhang P, Nowinski AK, Jiang S.

Acta Biomater. 2016 Aug;40:16-22. doi: 10.1016/j.actbio.2016.04.013. Epub 2016 Apr 7.

PMID:
27063489
8.

Pilot program on distance training in spirometry testing - the technology feasibility study.

Nowiński A, Romański E, Bieleń P, Bednarek M, Puścińska E, Goljan-Geremek A, Pływaczewski R, Śliwinski P.

Pneumonol Alergol Pol. 2015;83(6):431-5. doi: 10.5603/PiAP.2015.0071.

9.

The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study.

Nowiński A, Puścińska E, Goljan A, Peradzynska J, Bednarek M, Korzybski D, Kamiński D, Stokłosa A, Czystowska M, Śliwiński P, Górecka D.

Clin Respir J. 2017 Sep;11(5):648-656. doi: 10.1111/crj.12398. Epub 2015 Nov 18.

PMID:
26470754
10.

Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.

Goljan-Geremek A, Bednarek M, Franczuk M, Puścińska E, Nowiński A, Czystowska M, Kamiński D, Korzybski D, Stokłosa A, Kowalska A, Wojda E, Sliwiński P, Burakowska B, Ptak J, Barańska I, Drygalska A, Małek G, Bestry I, Wesołowski S, Kram M, Górecka D.

Pneumonol Alergol Pol. 2014;82(6):518-33. doi: 10.5603/PiAP.2014.0069.

11.

Achieving One-step Surface Coating of Highly Hydrophilic Poly(Carboxybetaine Methacrylate) Polymers on Hydrophobic and Hydrophilic Surfaces.

Sundaram HS, Han X, Nowinski AK, Brault ND, Li Y, Ella-Menye JR, Amoaka KA, Cook KE, Marek P, Senecal K, Jiang S.

Adv Mater Interfaces. 2014 Sep;1(6). pii: 1400071. doi: 10.1002/admi.201400071. Epub 2014 May 27.

12.

One-step dip coating of zwitterionic sulfobetaine polymers on hydrophobic and hydrophilic surfaces.

Sundaram HS, Han X, Nowinski AK, Ella-Menye JR, Wimbish C, Marek P, Senecal K, Jiang S.

ACS Appl Mater Interfaces. 2014 May 14;6(9):6664-71. doi: 10.1021/am500362k. Epub 2014 Apr 30.

PMID:
24730392
13.

Sensitive and fast detection of fructose in complex media via symmetry breaking and signal amplification using surface-enhanced Raman spectroscopy.

Sun F, Bai T, Zhang L, Ella-Menye JR, Liu S, Nowinski AK, Jiang S, Yu Q.

Anal Chem. 2014 Mar 4;86(5):2387-94. doi: 10.1021/ac4040983. Epub 2014 Feb 17.

PMID:
24502256
14.

Biologically inspired stealth peptide-capped gold nanoparticles.

Nowinski AK, White AD, Keefe AJ, Jiang S.

Langmuir. 2014 Feb 25;30(7):1864-70. doi: 10.1021/la404980g. Epub 2014 Feb 7.

PMID:
24483727
15.

Fatal clinical outcome in a patient with sarcoidosis-lymphoma syndrome.

Goljan-Geremek A, Puścińska E, Bednarek M, Nowiński A, Kamiński D, Ptak J, Bestry I, Langfort R, Staszewska M, Gorecka D.

Pneumonol Alergol Pol. 2013;81(6):542-9.

16.

Free energy of solvated salt bridges: a simulation and experimental study.

White AD, Keefe AJ, Ella-Menye JR, Nowinski AK, Shao Q, Pfaendtner J, Jiang S.

J Phys Chem B. 2013 Jun 20;117(24):7254-9. doi: 10.1021/jp4024469. Epub 2013 Jun 11.

PMID:
23697872
17.

Impact of mild anaemia on dyspnoea during exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease.

Nowiński A, Kamiński D, Kram M, Korzybski D, Stokłosa A, Górecka D.

Pneumonol Alergol Pol. 2013;81(3):200-6.

18.

Standardizing and simplifying analysis of peptide library data.

White AD, Keefe AJ, Nowinski AK, Shao Q, Caldwell K, Jiang S.

J Chem Inf Model. 2013 Feb 25;53(2):493-9. doi: 10.1021/ci300484q. Epub 2013 Feb 4.

PMID:
23327110
19.

Screening nonspecific interactions of peptides without background interference.

Keefe AJ, Caldwell KB, Nowinski AK, White AD, Thakkar A, Jiang S.

Biomaterials. 2013 Mar;34(8):1871-7. doi: 10.1016/j.biomaterials.2012.11.014. Epub 2012 Dec 14.

20.

The EvA study: aims and strategy.

Ziegler-Heitbrock L, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Häussinger K, Brightling C, Gupta S, Parr D, Subramanian D, Singh D, Kolsum U, Boschetto P, Potena A, Gorecka D, Nowinski A, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Bals R, Hohlfeld JM, Welte T, Venge P, Gut I, Boland A, Olaso R, Hager J, Hiemstra P, Rabe KF, Unmüssig M, Müller-Quernheim J, Prasse A.

Eur Respir J. 2012 Oct;40(4):823-9. Epub 2012 Mar 22.

21.

Sequence, structure, and function of peptide self-assembled monolayers.

Nowinski AK, Sun F, White AD, Keefe AJ, Jiang S.

J Am Chem Soc. 2012 Apr 4;134(13):6000-5. doi: 10.1021/ja3006868. Epub 2012 Mar 22.

22.

[Autoimmunological pulmonary alveolar proteinosis--case report].

Stokłosa A, Radzikowska E, Barańska I, Langfort R, Nowiński A, Kamiński D, Górecka D.

Pneumonol Alergol Pol. 2012;80(1):82-6. Polish.

23.

[The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease].

Nowiński A, Kamiński D, Korzybski D, Stokłosa A, Górecka D.

Pneumonol Alergol Pol. 2011;79(6):388-96. Polish.

24.

Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.

Nowiński A, Jabłońska-Skwiecińska E, Wojda E, Bieleń P, Ptak J, Sliwinski P, Górecka D.

Pneumonol Alergol Pol. 2007;75(3):283-8.

PMID:
17966106
25.

Oxidative stress in the external intercostal muscles of patients with obstructive sleep apnoea.

Barreiro E, Nowinski A, Gea J, Sliwinski P.

Thorax. 2007 Dec;62(12):1095-101. Epub 2007 Jun 15.

26.
27.

[The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].

Kuca P, Kamiński D, Campbell E, Kołakowski J, Goljan-Geremek A, Puścińska E, Bieleń P, Nowiński A, Wojda E, Hawryłkiewicz I, Sliwiński P, Górecka D.

Pneumonol Alergol Pol. 2004;72(9-10):420-3. Polish.

PMID:
16021998
28.

[Effect of treatment for nicotine dependence in patients with COPD].

Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J.

Pneumonol Alergol Pol. 2003;71(9-10):411-7. Polish.

PMID:
15052977
29.

Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate.

Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J.

Chest. 2003 Jun;123(6):1916-23.

PMID:
12796168
30.

[Primary ciliary dyskinesia--Kartagener's syndrome and fertile male].

Nowiński A, Hawryłkjewicz I, Sulikowska-Rowińska A, Górecka D.

Pneumonol Alergol Pol. 2002;70(5-6):312-7. Polish.

PMID:
12518631
31.

[Organizing pneumonia--diagnostic and therapeutic problems].

Nowiński A, Burakowska B, Bestry I, Langfort R, Górecka D.

Pneumonol Alergol Pol. 2002;70(5-6):305-11. Polish.

PMID:
12518630
32.

[Early detection of airflow limitation in smokers in remote areas of Poland].

Nowiński A, Pływaczewski R, Kołakowski J, Zieliński J.

Pneumonol Alergol Pol. 2002;70(3-4):148-54. Polish.

PMID:
12271962
33.

[Early detection of COPD in smokers from Warsaw using spirometric screening].

Bednarek M, Pływaczewski R, Górecka D, Puścińska E, Nowiński A, Zieliński J.

Pneumonol Alergol Pol. 2002;70(3-4):139-47. Polish.

PMID:
12271961
34.

[Predictors of success in smoking cessation among participants of spirometric screening for COPD].

Górecka D, Bednarek M, Nowiński A, Kamiński D, Bieleń P, Kołakowski J, Pływaczewski R, Goljan A, Puścińska E, Zieliński J.

Pneumonol Alergol Pol. 2001;69(11-12):611-6. Polish.

PMID:
12134436
35.

[Effects of spirometric screening in the community on smoking cessation].

Czajkowska-Malinowska M, Nowiński A, Górecka D, Zieliński J.

Pneumonol Alergol Pol. 2001;69(9-10):524-9. Polish.

PMID:
11928658
36.

[Early, targeted population based screening for COPD. Preliminary study].

Pływaczewski R, Bednarek M, Górecka D, Puścińska E, Nowiński A, Zieliński J.

Pneumonol Alergol Pol. 1999;67(9-10):416-21. Polish.

PMID:
10808385
37.

[Quality of sleep and periodic breathing in healthy individuals working at an altitude of 3700 meters].

Pływaczewski R, Pałasiewicz G, Sarybaev AS, Le Roux J, Usupbaeva DA, Nowiński A, Mirrakhimov MM, Zieliński J.

Pol Arch Med Wewn. 1999 Feb;101(2):117-21. Polish.

PMID:
10723225
38.

Incidence of nocturnal desaturation while breathing oxygen in COPD patients undergoing long-term oxygen therapy.

Plywaczewski R, Sliwinski P, Nowinski A, Kaminski D, Zieliński J.

Chest. 2000 Mar;117(3):679-83.

PMID:
10712991
39.

[Research in the hospitals].

Nowinski A, Ripa JC.

Educ Med Salud. 1980;14(4):355-70. Spanish.

PMID:
7449703
40.

[Case of multiform rhabdomyosarcoma of the bladder in an adult].

Musierowicz A, Zimnoch L, Nowiński A, Czerniawski J, Chilimoniuk M.

Pol Przegl Chir. 1977 Jun;49(6a):773-5. Polish. No abstract available.

PMID:
887522
41.

[Unusual case of suprapubic fistula with canal passing the base of the small intestine mesentery].

Musierowicz A, Nowiński A.

Pol Przegl Chir. 1976 Oct;48(10 A):1341-2. Polish. No abstract available.

PMID:
981042
42.

[Pedunculated papilloma of the ureter protruding into the urinary bladder].

Nowiński A, Musierowicz A, Czerniawski J.

Pol Przegl Chir. 1976 Oct;48(10 A):1337-9. Polish. No abstract available.

PMID:
981041
43.

[Adenocarcinoma in exstrophic bladder].

Musierowicz A, Nowiński A, Czerniawski J, Chilimoniuk M.

Pol Przegl Chir. 1976 Jun;48(6A):807-8. Polish. No abstract available.

PMID:
951330
44.

[A case of primary carcinoma of the male urethra].

Musierowicz A, Nowiński A, Czerniawski J, Chilimoniuk M.

Pol Przegl Chir. 1976 Feb;48(2 A):285-7. Polish. No abstract available.

PMID:
1250793
45.

[A case of clear-cell renal carcinoma coexisting with renolithiasis diagnosed prior to surgery].

Czerniawski J, Musierowicz A, Nowiński A, Chilimoniuk M.

Pol Przegl Chir. 1976 Feb;48(2 A):277-9. Polish. No abstract available.

PMID:
1250791
46.

[Coexistence of primary renal pelvis carcinoma in a patient with congenital hydronephrosis and renal cyst].

Musierowicz A, Czerniawski J, Chilimoniuk M, Nowiński A.

Pol Przegl Chir. 1976 Feb;48(2 A):269-71. Polish. No abstract available.

PMID:
1250790
47.

[Considerations on malignant transformation of congenital extrophic bladder].

Musierowicz A, Nowiński A.

Wiad Lek. 1976 Jan 15;29(2):153-5. Polish. No abstract available.

PMID:
1251625
48.

[Use of ureterocutaneostomy in suprapubic urinary diversion in patients with inoperable bladder and uterus neoplasms].

Musierowicz A, Nowiński A, Czerniawski J, Chilimoniuk M.

Pol Przegl Chir. 1975 Nov;47(11A):1455-7. Polish. No abstract available.

PMID:
1208241
49.

[Evaluation of Y body in meiosis in men by means of fluoroscopy].

Wiśniewski L, Nowińskí A, Kobierski W.

Ginekol Pol. 1973 Jun;44(6):635-40. Polish. No abstract available.

PMID:
4720460
50.

[Dissolution of urinary calculi by means of a solution G].

Nowiński A, Giedrojc-Juraha W.

Pol Przegl Chir. 1972 Feb;44(2):Suppl:443-5. Polish. No abstract available.

PMID:
5020060

Supplemental Content

Loading ...
Support Center